Tier 2 · Liquid 3000

Kiniksa Pharmaceuticals International, plc

KNSA · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$61.93
+0.00%
Coverage
Tier 2
Tier 2 · Liquid 3000
SEC CIK
0001730430
Liquidity rank
#1807
Observed dollar volume

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$677.56M2025-12-310001104659-26-019168
Annual diluted EPS0.752025-12-310001104659-26-019168
Quarterly revenue$214.27M2026-03-310001104659-26-050359
Quarterly diluted EPS0.272026-03-310001104659-26-050359

SEC EDGAR Frames batch generated 2026-07-16T23:27:27.064Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Dividends

Trailing 12 months
Not published
Latest payment
Not published

Yahoo Finance corporate actions. Window: 2025-07-17 through 2026-07-17.

Seasonality

MonthMean returnPositiven

Monthly close-to-close returns, trailing 15 years where Yahoo history is available.

Sector news

No matching sector headlines were returned in the 72-hour window.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerDHR · Tier 1 peerTMO · Tier 1 peerPFE · Tier 1 peer

Provenance

IdentitySEC company tickers and Nasdaq Symbol Directory
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames